Whitehead Institute researchers have uncovered a molecular mechanism underlying type 2 diabetes. The new finding reveals that insulin receptors, the signaling molecules that sense insulin, normally function by clustering together in cells and that this clustering is defective in insulin resistance, the basis of type 2 diabetes. The researchers hope that this work will bring about a better understanding of diabetes at a molecular level and lead to the development of new therapies.